Which has higher valuation and earnings, GH or NTRA?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 16.99 -$416.28M -$3.39 N/A Natera $2.31B 12.88 -$208.16M -$1.63 N/A

Is GH or NTRA more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Guardant Health -40.10% N/A -26.42% Natera -9.05% -14.74% -10.27%

Does the media prefer GH or NTRA?

In the previous week, Natera had 9 more articles in the media than Guardant Health. MarketBeat recorded 24 mentions for Natera and 15 mentions for Guardant Health. Natera's average media sentiment score of 1.06 beat Guardant Health's score of 0.06 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Natera 15 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BTSG or NTRA?

In the previous week, Natera had 21 more articles in the media than BrightSpring Health Services. MarketBeat recorded 24 mentions for Natera and 3 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.25 beat Natera's score of 1.06 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 15 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to NTRA or FMS?

In the previous week, Natera had 21 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 24 mentions for Natera and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 1.06 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 15 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CELC or NTRA more profitable?

Celcuity has a net margin of 0.00% compared to Natera's net margin of -9.05%. Natera's return on equity of -14.74% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% Natera -9.05% -14.74% -10.27%

Does the media prefer CELC or NTRA?

In the previous week, Natera had 6 more articles in the media than Celcuity. MarketBeat recorded 24 mentions for Natera and 18 mentions for Celcuity. Natera's average media sentiment score of 1.06 beat Celcuity's score of 0.22 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 2 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 4 Very Negative mention(s) Neutral Natera 15 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, NTRA or HIMS?

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Natera $2.31B 12.88 -$208.16M -$1.63 N/A Hims & Hers Health $2.35B 2.57 $128.37M -$0.09 N/A

Is NTRA or HIMS more profitable?

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Natera -9.05% -14.74% -10.27% Hims & Hers Health -0.56% 6.10% 1.52%

Does the media favor NTRA or HIMS?

In the previous week, Hims & Hers Health had 2 more articles in the media than Natera. MarketBeat recorded 26 mentions for Hims & Hers Health and 24 mentions for Natera. Natera's average media sentiment score of 1.06 beat Hims & Hers Health's score of 0.63 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 15 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 7 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Natera (NTRA) Competitors

$210.53 -2.20 (-1.03%)

As of 10:33 AM Eastern

Compare

NTRA vs. GH, BTSG, FMS, CELC, and HIMS

Should you buy Natera stock or one of its competitors? MarketBeat compares Natera with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Natera include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does Natera compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

Guardant Health has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market. Comparatively, Natera has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 5.1% of Natera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	16.99	-$416.28M	-$3.39	N/A
Natera	$2.31B	12.88	-$208.16M	-$1.63	N/A

In the previous week, Natera had 9 more articles in the media than Guardant Health. MarketBeat recorded 24 mentions for Natera and 15 mentions for Guardant Health. Natera's average media sentiment score of 1.06 beat Guardant Health's score of 0.06 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Natera	15 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardant Health presently has a consensus price target of $136.37, indicating a potential upside of 8.41%. Natera has a consensus price target of $256.81, indicating a potential upside of 23.78%. Given Natera's higher probable upside, analysts clearly believe Natera is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.95
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.85

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Natera	-9.05%	-14.74%	-10.27%

Summary

Natera beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Natera compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

BrightSpring Health Services has a net margin of 2.27% compared to Natera's net margin of -9.05%. BrightSpring Health Services' return on equity of 14.63% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Natera	-9.05%	-14.74%	-10.27%

BrightSpring Health Services currently has a consensus target price of $57.64, indicating a potential downside of 4.37%. Natera has a consensus target price of $256.81, indicating a potential upside of 23.78%. Given Natera's higher possible upside, analysts clearly believe Natera is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.85

99.9% of Natera shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 5.1% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

BrightSpring Health Services has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$13.65B	0.86	$190.67M	$1.41	42.75
Natera	$2.31B	12.88	-$208.16M	-$1.63	N/A

In the previous week, Natera had 21 more articles in the media than BrightSpring Health Services. MarketBeat recorded 24 mentions for Natera and 3 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.25 beat Natera's score of 1.06 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	15 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market. Comparatively, Natera has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market.

Summary

BrightSpring Health Services beats Natera on 11 of the 16 factors compared between the two stocks.

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Natera (NASDAQ:NTRA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Natera's net margin of -9.05%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

99.9% of Natera shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.1% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Natera has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

In the previous week, Natera had 21 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 24 mentions for Natera and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 1.06 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	15 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Natera currently has a consensus price target of $256.81, indicating a potential upside of 23.78%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, indicating a potential upside of 34.36%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.85
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	12.88	-$208.16M	-$1.63	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.51	$1.11B	$1.90	10.97

Summary

Natera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Natera compare to Celcuity?

Celcuity (NASDAQ:CELC) and Natera (NASDAQ:NTRA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

In the previous week, Natera had 6 more articles in the media than Celcuity. MarketBeat recorded 24 mentions for Natera and 18 mentions for Celcuity. Natera's average media sentiment score of 1.06 beat Celcuity's score of 0.22 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	2 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	4 Very Negative mention(s)	Neutral
Natera	15 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market. Comparatively, Natera has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market.

Celcuity has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Natera	$2.31B	12.88	-$208.16M	-$1.63	N/A

Celcuity currently has a consensus target price of $153.73, indicating a potential upside of 71.69%. Natera has a consensus target price of $256.81, indicating a potential upside of 23.78%. Given Celcuity's higher probable upside, research analysts clearly believe Celcuity is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.85

Celcuity has a net margin of 0.00% compared to Natera's net margin of -9.05%. Natera's return on equity of -14.74% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Natera	-9.05%	-14.74%	-10.27%

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 5.1% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Natera beats Celcuity on 11 of the 16 factors compared between the two stocks.

How does Natera compare to Hims & Hers Health?

Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	12.88	-$208.16M	-$1.63	N/A
Hims & Hers Health	$2.35B	2.57	$128.37M	-$0.09	N/A

In the previous week, Hims & Hers Health had 2 more articles in the media than Natera. MarketBeat recorded 26 mentions for Hims & Hers Health and 24 mentions for Natera. Natera's average media sentiment score of 1.06 beat Hims & Hers Health's score of 0.63 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	15 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	11 Very Positive mention(s)	7 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Natera currently has a consensus target price of $256.81, suggesting a potential upside of 23.78%. Hims & Hers Health has a consensus target price of $28.70, suggesting a potential upside of 10.00%. Given Natera's stronger consensus rating and higher probable upside, equities research analysts plainly believe Natera is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.85
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

99.9% of Natera shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.1% of Natera shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Natera has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market.

Summary

Hims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks.

Get Natera News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTRA vs. The Competition

Export

Metric	Natera	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$29.71B	$8.45B	$6.24B	$12.48B
Dividend Yield	N/A	1.77%	2.69%	5.30%
P/E Ratio	-127.28	22.02	21.09	24.35
Price / Sales	12.88	25.53	561.45	126.00
Price / Cash	N/A	90.05	42.31	57.88
Price / Book	16.76	4.97	9.95	6.72
Net Income	-$208.16M	$178.24M	$3.56B	$337.08M
7 Day Performance	2.15%	-1.66%	-0.07%	1.63%
1 Month Performance	0.09%	3.31%	5.08%	6.29%
1 Year Performance	29.55%	1.65%	28.39%	35.50%

Natera Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTRA Natera	4.3123 of 5 stars	$210.53 -1.0%	$256.81 +22.0%	+32.6%	$30.15B	$2.31B	N/A	6,140	Positive News Analyst Upgrade
GH Guardant Health	1.7961 of 5 stars	$129.14 -0.4%	$129.79 +0.5%	+209.2%	$17.20B	$982.02M	N/A	2,506	Analyst Upgrade Gap Up
BTSG BrightSpring Health Services	4.1749 of 5 stars	$59.98 -2.8%	$57.00 -5.0%	+148.0%	$11.96B	$12.91B	49.74	23,500	Positive News Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.6838 of 5 stars	$21.05 -2.4%	$28.00 +33.0%	-28.7%	$11.65B	$22.20B	11.08	1,488	Gap Down
CELC Celcuity	3.405 of 5 stars	$122.96 -7.5%	$150.27 +22.2%	+686.7%	$6.48B	N/A	N/A	40	Trending News Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTRA) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, CELC, and HIMS

How does Natera compare to Guardant Health?

Summary

How does Natera compare to BrightSpring Health Services?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Natera compare to Celcuity?

Summary

How does Natera compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, CELC, and HIMS

How does Natera compare to Guardant Health?

Which has more risk and volatility, GH or NTRA?

Do insiders and institutionals believe in GH or NTRA?

Which has higher valuation and earnings, GH or NTRA?

Does the media prefer GH or NTRA?

Do analysts prefer GH or NTRA?

Is GH or NTRA more profitable?

Summary

How does Natera compare to BrightSpring Health Services?

Is BTSG or NTRA more profitable?

Do analysts recommend BTSG or NTRA?

Do institutionals & insiders believe in BTSG or NTRA?

Which has better earnings & valuation, BTSG or NTRA?

Does the media prefer BTSG or NTRA?

Which has more volatility & risk, BTSG or NTRA?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Is NTRA or FMS more profitable?

Do insiders & institutionals have more ownership in NTRA or FMS?

Which has more risk and volatility, NTRA or FMS?

Does the media refer more to NTRA or FMS?

Do analysts recommend NTRA or FMS?

Which has preferable earnings and valuation, NTRA or FMS?

Summary

How does Natera compare to Celcuity?

Does the media prefer CELC or NTRA?

Which has more volatility & risk, CELC or NTRA?

Which has better earnings & valuation, CELC or NTRA?

Do analysts prefer CELC or NTRA?

Is CELC or NTRA more profitable?

Do insiders & institutionals have more ownership in CELC or NTRA?

Summary

How does Natera compare to Hims & Hers Health?

Is NTRA or HIMS more profitable?

Which has higher earnings and valuation, NTRA or HIMS?

Does the media favor NTRA or HIMS?

Do analysts prefer NTRA or HIMS?

Do institutionals and insiders believe in NTRA or HIMS?

Which has more risk and volatility, NTRA or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools